
Acorda Therapeutics ACOR
Quartalsbericht 2024-Q1
hinzugefügt 14.05.2024
Acorda Therapeutics P/S 2011-2026 | ACOR
P/S Jährlich Acorda Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.142 | 0.115 | 0.0823 | 0.356 | 0.524 | 1.64 | 2.07 | 1.71 | 3.16 | 4.26 | 3.58 | 3.72 | 3.42 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 4.26 | 0.0823 | 1.91 |
P/S anderer Aktien in der Pharmaeinzelhändler
| Name | P/S | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
Aclaris Therapeutics
ACRS
|
8.13 | $ 2.69 | 0.19 % | $ 208 M | ||
|
Ascendis Pharma A/S
ASND
|
947 | $ 208.25 | -2.36 % | $ 5 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
Alterity Therapeutics Limited
ATHE
|
131 | $ 3.42 | 6.54 % | $ 8.23 B | ||
|
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Albireo Pharma
ALBO
|
13.3 | - | -0.23 % | $ 916 M | ||
|
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M | ||
|
Alpine Immune Sciences
ALPN
|
8.94 | - | - | $ 2.17 B | ||
|
Ampio Pharmaceuticals
AMPE
|
106 | - | -11.43 % | $ 502 K | ||
|
Can-Fite BioPharma Ltd.
CANF
|
759 | $ 4.35 | -7.64 % | $ 9.47 B | ||
|
Aravive
ARAV
|
6.61 | - | -13.39 % | $ 1.45 M | ||
|
Arena Pharmaceuticals
ARNA
|
105 K | - | -6.81 % | $ 3.04 B | ||
|
Athersys
ATHX
|
253 | - | 3.77 % | $ 22.4 M | ||
|
AIkido Pharma
AIKI
|
1.08 | - | 1.93 % | $ 17.4 M | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
Autolus Therapeutics plc
AUTL
|
1.37 K | $ 1.91 | -2.31 % | $ 487 M | ||
|
Acasti Pharma
ACST
|
0.203 | - | 4.01 % | $ 150 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
34 | - | -15.15 % | $ 60.3 M | ||
|
BioNTech SE
BNTX
|
35.7 | $ 98.56 | -1.52 % | $ 27.2 B | ||
|
Amphastar Pharmaceuticals
AMPH
|
1.79 | $ 27.72 | 1.43 % | $ 1.34 B | ||
|
CureVac N.V.
CVAC
|
281 | - | - | $ 867 M | ||
|
Acer Therapeutics
ACER
|
25.8 | - | 2.71 % | $ 14 M | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
18.6 | $ 11.49 | -2.21 % | $ 743 M | ||
|
BioDelivery Sciences International
BDSI
|
1.85 | - | -4.8 % | $ 255 M | ||
|
Axon Enterprise
AXON
|
19.1 | $ 611.74 | -1.48 % | $ 46.3 B | ||
|
Ayala Pharmaceuticals
AYLA
|
11.2 | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
0.237 | $ 2.71 | -4.24 % | $ 17 M | ||
|
BeiGene, Ltd.
BGNE
|
66.4 | - | 0.49 % | $ 251 B | ||
|
AstraZeneca PLC
AZN
|
2.17 | $ 94.15 | -1.06 % | $ 96.9 B | ||
|
Bellicum Pharmaceuticals
BLCM
|
5.55 | - | -9.72 % | $ 5.89 M | ||
|
Brickell Biotech
BBI
|
1.42 | - | -5.38 % | $ 6.06 M | ||
|
Burford Capital Limited
BUR
|
6.35 | $ 9.29 | -0.05 % | $ 1.51 B | ||
|
Berkeley Lights
BLI
|
1.49 | - | -7.31 % | $ 87 M | ||
|
Biogen
BIIB
|
2 | $ 185.27 | -0.88 % | $ 27 B | ||
|
Abeona Therapeutics
ABEO
|
42.7 | $ 5.1 | -2.39 % | $ 109 M | ||
|
bluebird bio
BLUE
|
2.27 | - | - | $ 546 M | ||
|
ADiTx Therapeutics
ADTX
|
0.442 | $ 0.84 | -0.24 % | $ 11.1 K | ||
|
Advaxis
ADXS
|
144 | - | -9.65 % | $ 45.9 M |